Skip to main content

Table 1 Clinical characteristics of control subjects and CAD patients with type 2 diabetes

From: Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes

  Control Subjects CAD Patients P value
n 550 560  
Age (years) 61.1 ± 7.9 66.0 ± 6.9 < 0.001
Male subjects (%) 42.5 55.4 < 0.001
BMI (kg/m 2 ) 22.0 ± 3.4 24.3 ± 3.9 < 0.001
Diabetes duration (years) 10.8 ± 3.6 12.0 ± 4.4 < 0.001
Current smoking (%) 32.0 38.4 0.026
Hypertension (%) 61.8 68.9 0.013
Fasting glucose (mmol/l) 6.49 ± 2.71 6.86 ± 3.10 0.038
2-h post-OGTT glucose (mmol/l) 7.57 ± 1.21 8.40 ± 2.07 < 0.001
HbA1c (%) 7.18 ± 1.01 7.53 ± 1.22 < 0.001
Triglyceride (mmol/l) 1.46 ± 0.21 1.49 ± 0.26 0.023
HDL cholesterol (mmol/l) 1.33 ± 0.28 1.23 ± 0.22 < 0.001
LDL cholesterol (mmol/l) 3.18 ± 0.84 3.25 ± 0.83 0.135
Adiponectin (μg/ml) 7.11 (6.90 - 7.33) 5.90 (5.69 - 6.12) < 0.001
Gensini score 13.4 (12.6 - 14.2) 22.5 (21.1 - 24.1) < 0.001
Sullivan Extent score 15.9 (13.9 - 16.6) 28.7 (25.5 - 31.1) < 0.001
Treatment    
Diet only (%) 11.3 11.4 0.935
Oral agents (%) 57.6 53.2 0.138
Insulin (%) 31.1 35.4 0.131
  1. Data are expressed as mean ± SD or geometric mean (95% confidence interval). BMI = body mass index; CAD = coronary artery disease; HbA1c = hemoglobin A1C; HDL cholesterol = high-density lipoprotein cholesterol; LDL cholesterol = low-density lipoprotein cholesterol.